Imiquimod

咪喹莫特

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameImiquimod
Drug Alias NameBeselna Cream 5%咪奎莫特咪喹莫德ImiquimodumZyclara +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsOral Squamous Cell CarcinomaKeratosisScleroderma, Localized +[35] 
Global Approved IndicationsKeratosisKeratosis, ActinicCarcinoma, Basal Cell +[5] 
Approved Indications in ChinaCondylomata Acuminata
Original Approved Country/TerritoryUnited States
Original Approved Date1997/02/27
Country/TerritoryBelgiumCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator Companies3m Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInova PharmaceuticalsViatris Healthcare LtdMelanoma And Skin Cancer Trials Ltd +[12] 
Inactive CompaniesTelormedix Sa3mMaastricht University Medical Center +[27] 
Active IndicationsOral Squamous Cell CarcinomaKeratosisMouth Diseases +[13] 
Inactive IndicationsScleroderma, LocalizedKeloidPort-Wine Stain +[22] 

Other Information

ATC CodeD06BB10
Related LinksWikipediaDrugBankKEGG